- Home
- FERG vs TEVA Comparison
FERG vs TEVA Comparison
Compare FERG & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FERG | TEVA |
|---|---|---|
| Founded | 1887 | 1901 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Miscellaneous | Biotechnology: Pharmaceutical Preparations |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.4B | 40.5B |
| IPO Year | 2024 | 1996 |
Fundamental Metrics
Financial Performance| Metric | FERG | TEVA |
|---|---|---|
| Price | $245.01 | $36.61 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 8 |
| Target Price | ★ $268.54 | $38.63 |
| AVG Volume (30 Days) | 3.4M | ★ 5.5M |
| Earning Date | 06-02-2026 | 04-29-2026 |
| Dividend Yield | ★ 1.39% | N/A |
| EPS Growth | 9.26 | ★ 183.45 |
| EPS | ★ 5.56 | N/A |
| Revenue | ★ $30,762,000,000.00 | N/A |
| Revenue This Year | $7.98 | N/A |
| Revenue Next Year | $5.86 | $2.97 |
| P/E Ratio | $44.64 | ★ N/A |
| Revenue Growth | ★ 3.80 | N/A |
| 52 Week Low | $207.64 | $17.33 |
| 52 Week High | $271.64 | $37.39 |
Technical Indicators
Market Signals| Indicator | FERG | TEVA |
|---|---|---|
| Relative Strength Index (RSI) | 52.75 | 66.67 |
| Support Level | $220.73 | $30.42 |
| Resistance Level | $245.15 | $37.17 |
| Average True Range (ATR) | 7.57 | 1.04 |
| MACD | 0.23 | 0.34 |
| Stochastic Oscillator | 49.91 | 88.48 |
Price Performance
Historical ComparisonAbout FERG Ferguson plc
Ferguson distributes plumbing and HVAC products to North American repair, maintenance, and improvement, new construction, and civil infrastructure markets. It serves over 1 million customers and sources products from 37,000 suppliers. Ferguson engages customers through approximately 1,700 North American branches, over the phone, online, and in residential showrooms. The firm sold its UK business in 2021 and is now solely focused on the North American market.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.